China Oncology ›› 2023, Vol. 33 ›› Issue (6): 581-588.doi: 10.19401/j.cnki.1007-3639.2023.06.005
• Article • Previous Articles Next Articles
REN Hengyu(), HAO Shuang, CHEN Jiajian, YANG Benlong, CAO Ayong, LIU Guangyu, SHAO Zhimin, WU Jiong(
)
Received:
2023-02-27
Revised:
2023-05-12
Online:
2023-06-30
Published:
2023-07-26
Share article
CLC Number:
REN Hengyu, HAO Shuang, CHEN Jiajian, YANG Benlong, CAO Ayong, LIU Guangyu, SHAO Zhimin, WU Jiong. Current status and focus of breast reconstruction research in China and abroad: a bibliometric study[J]. China Oncology, 2023, 33(6): 581-588.
Tab. 1
Top 10 authors with the most published articles and cited frequency abroad"
Rank | Author with the highest number of publications | Publications | The most cited author | Citations |
---|---|---|---|---|
1 | Lee B T | 56 | Pusic A L | 1 332 |
2 | Pusic A L | 48 | Wilkins E G | 1 121 |
3 | Lin S J | 47 | Hamill J B | 1 040 |
4 | Momeni A | 39 | Qi J | 982 |
5 | Teotia S S | 39 | Kim H M | 896 |
6 | Haddock N T | 38 | Momoh A O | 562 |
7 | Momoh A O | 37 | Lee B T | 540 |
8 | Matros E | 36 | Lin S J | 529 |
9 | Choi M | 36 | Clemens M W | 504 |
10 | Rosson G D | 35 | Matros E | 457 |
Tab. 2
Top 10 institutions by number of publications"
Rank | Institution | Publication n (%) |
---|---|---|
1 | The University of Texas MD Anderson Cancer Center | 144 (3.00) |
2 | Harvard Medical School | 139 (2.89) |
3 | Memorial Sloan-Kettering Cancer Center | 125 (2.60) |
4 | Stanford Universitiy | 113 (2.35) |
5 | University of Michigan | 102 (2.12) |
6 | Mayo Clinic | 81 (1.68) |
7 | University of Toronto | 73 (1.52) |
8 | Brigham and Women‘s Hospital | 70 (1.45) |
9 | Maastricht University | 69 (1.43) |
10 | University of Ulsan | 67 (0.96) |
Tab. 4
Top 10 keywords in publications of breast surgery and oncology surgery"
Rank | Keywords | Frequency |
---|---|---|
1 | Breast cancer | 447 |
2 | Breast reconstruction | 242 |
3 | Complication rate | 153 |
4 | Implant | 147 |
5 | Immediate breast reconstruction | 127 |
6 | Quality of life | 122 |
7 | Image | 111 |
8 | Chemotherapy | 96 |
9 | Flap | 83 |
10 | Survival | 82 |
[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.v71.3 |
[2] | 郭瑢, 修秉虬, 苏永辉, 等. 中国乳腺癌术后植入物乳房重建现况调查[J]. 中华外科杂志, 2019, 57(8): 616-621. |
GUO R, XIU B Q, SU Y H, et al. Current practice of implant-based breast reconstruction: results from China national practice questionnaire survey[J]. Chin J Surg, 2019, 57(8): 616-621. | |
[3] |
WANG J, XIU B Q, GUO R, et al. Autologous tissue reconstruction after mastectomy-a cross-sectional survey of 110 hospitals in China[J]. Eur J Surg Oncol, 2020, 46(12): 2202-2207.
doi: 10.1016/j.ejso.2020.07.008 pmid: 32807619 |
[4] |
BAKER B G, IRRI R, MACCALLUM V, et al. A prospective comparison of short-term outcomes of subpectoral and prepectoral strattice-based immediate breast reconstruction[J]. Plast Reconstr Surg, 2018, 141(5): 1077-1084.
doi: 10.1097/PRS.0000000000004270 pmid: 29697602 |
[5] |
O'CONNELL R L, DI MICCO R, KHABRA K, et al. Comparison of immediate versus delayed DIEP flap reconstruction in women who require postmastectomy radiotherapy[J]. Plast Reconstr Surg, 2018, 142(3): 594-605.
doi: 10.1097/PRS.0000000000004676 pmid: 29927832 |
[6] |
GAO Y, GE L, SHI S Z, et al. Global trends and future prospects of e-waste research: a bibliometric analysis[J]. Environ Sci Pollut Res Int, 2019, 26(17): 17809-17820.
doi: 10.1007/s11356-019-05071-8 |
[7] | LIANG C, LUO A, ZHONG Z. Knowledge mapping of medication literacy study: a visualized analysis using CiteSpace[J]. SAGE Open Med, 2018, 6: 2050312118800199. |
[8] |
LIANG Y D, LI Y, ZHAO J, et al. Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace[J]. J Pain Res, 2017, 10: 951-964.
doi: 10.2147/JPR |
[9] |
HO A Y, HU Z I, MEHRARA B J, et al. Radiotherapy in the setting of breast reconstruction: types, techniques, and timing[J]. Lancet Oncol, 2017, 18(12): e742-e753.
doi: 10.1016/S1470-2045(17)30617-4 pmid: 29208440 |
[10] |
LEE G K, SHECKTER C C. Breast reconstruction following breast cancer treatment-2018[J]. JAMA, 2018, 320(12): 1277-1278.
doi: 10.1001/jama.2018.12190 pmid: 30178060 |
[11] |
SANTOSA K B, QI J, KIM H M, et al. Long-term patient-reported outcomes in postmastectomy breast reconstruction[J]. JAMA Surg, 2018, 153(10): 891-899.
doi: 10.1001/jamasurg.2018.1677 pmid: 29926096 |
[12] | 叶京明, 辛灵, 王宇, 等. 推动乳腺癌患者乳房重建的专业化和规范化发展[J]. 中华外科杂志, 2019, 57(2): 88-91. |
YE J M, XIN L, WANG Y, et al. Breast reconstruction after mastectomy in breast cancer patients: specialization and standardization[J]. Chin J Surg, 2019, 57(2): 88-91. | |
[13] | CHEN Y, CHEN J J, CHEN J Y, et al. Current trends of breast reconstruction after mastectomy for breast cancer patients in China: a survey report[J]. Chin J Oncol, 2014, 36(11): 851-857. |
[14] |
TSANGARIS E, KLASSEN A F, KAUR M N, et al. Development and psychometric validation of the BREAST-Q sensation module for women undergoing post-mastectomy breast reconstruction[J]. Ann Surg Oncol, 2021, 28(12): 7842-7853.
doi: 10.1245/s10434-021-10094-y pmid: 33988795 |
[15] |
WILKINS E G, HAMILL J B, KIM H M, et al. Complications in postmastectomy breast reconstruction: one-year outcomes of the mastectomy reconstruction outcomes consortium (MROC) study[J]. Ann Surg, 2018, 267(1): 164-170.
doi: 10.1097/SLA.0000000000002033 pmid: 27906762 |
[16] | COOKE A L, DIAZ-ABELE J, HAYAKAWA T, et al. Radiation therapy versus no radiation therapy to the neo-breast following skin-sparing mastectomy and immediate autologous free flap reconstruction for breast cancer: patient-reported and surgical outcomes at 1 year-a mastectomy reconstruction outcomes consortium (MROC) substudy[J]. Int J Radiat Oncol Biol Phys, 2017, 99(1): 165-172. |
[17] |
NELSON J A, CHU J J, MCCARTHY C M, et al. BREAST-Q REACT: clinical reference values for the BREAST-Q in post-mastectomy breast reconstruction patients[J]. Ann Surg Oncol, 2022, 29(8): 5280-5293.
doi: 10.1245/s10434-022-11521-4 pmid: 35415816 |
[18] |
LOHMANDER F, LAGERGREN J, ROY P G, et al. Implant based breast reconstruction with acellular dermal matrix: safety data from an open-label, multicenter, randomized, controlled trial in the setting of breast cancer treatment[J]. Ann Surg, 2019, 269(5): 836-841.
doi: 10.1097/SLA.0000000000003054 pmid: 30308615 |
[19] |
KRASTEV T, VAN TURNHOUT A, VRIENS E, et al. Long-term follow-up of autologous fat transfer vs conventional breast reconstruction and association with cancer relapse in patients with breast cancer[J]. JAMA Surg, 2019, 154(1): 56-63.
doi: 10.1001/jamasurg.2018.3744 |
[20] |
POTTER S, CONROY E J, CUTRESS R I, et al. Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study[J]. Lancet Oncol, 2019, 20(2): 254-266.
doi: S1470-2045(18)30781-2 pmid: 30639093 |
[21] |
LOHMANDER F, LAGERGREN J, JOHANSSON H, et al. Effect of immediate implant-based breast reconstruction after mastectomy with and without acellular dermal matrix among women with breast cancer: a randomized clinical trial[J]. JAMA Netw Open, 2021, 4(10): e2127806.
doi: 10.1001/jamanetworkopen.2021.27806 |
[22] |
DIKMANS R E, NEGENBORN V L, BOUMAN M B, et al. Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial[J]. Lancet Oncol, 2017, 18(2): 251-258.
doi: S1470-2045(16)30668-4 pmid: 28012977 |
[23] |
RYU J M, KIM J Y, CHOI H J, et al. Robot-assisted nipple-sparing mastectomy with immediate breast reconstruction: an initial experience of the Korea robot-endoscopy minimal access breast surgery study group (KoREa-BSG)[J]. Ann Surg, 2022, 275(5): 985-991.
doi: 10.1097/SLA.0000000000004492 |
[24] |
JAGSI R, MOMOH A O, QI J, et al. Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction[J]. J Natl Cancer Inst, 2018, 110(2): 157-165.
doi: 10.1093/jnci/djx148 |
[25] |
HART S E, BROWN D L, KIM H M, et al. Association of clinical complications of chemotherapy and patient-reported outcomes after immediate breast reconstruction[J]. JAMA Surg, 2021, 156(9): 847-855.
doi: 10.1001/jamasurg.2021.2239 pmid: 34160601 |
[26] |
OLSEN M A, NICKEL K B, FOX I K, et al. Comparison of wound complications after immediate, delayed, and secondary breast reconstruction procedures[J]. JAMA Surg, 2017, 152(9): e172338.
doi: 10.1001/jamasurg.2017.2338 |
[27] |
CHO M J, HADDOCK N T, GASSMAN A A, et al. Use of composite arterial and venous grafts in microsurgical breast reconstruction: technical challenges and lessons learned[J]. Plast Reconstr Surg, 2018, 142(4): 867-870.
doi: 10.1097/PRS.0000000000004730 |
[28] |
ENGEL H, LIN C Y, HUANG J J, et al. Outcomes of lymphedema microsurgery for breast cancer-related lymphedema with or without microvascular breast reconstruction[J]. Ann Surg, 2018, 268(6): 1076-1083.
doi: 10.1097/SLA.0000000000002322 pmid: 28594742 |
[29] |
D'ANGELO A, CINA A, MACRÌ G, et al. Conventional CT versus dedicated CT angiography in DIEP flap planning: a feasibility study[J]. J Pers Med, 2021, 11(4): 277.
doi: 10.3390/jpm11040277 |
[30] |
CHATTHA A, BUCKNOR A, CHEN A D, et al. Indocyanine green angiography use in breast reconstruction: a national analysis of outcomes and cost in 110 320 patients[J]. Plast Reconstr Surg, 2018, 141(4): 825-832.
doi: 10.1097/PRS.0000000000004195 |
[31] |
COHEN W A, MUNDY L R, BALLARD T N, et al. The BREAST-Q in surgical research: a review of the literature 2009-2015[J]. J Plast Reconstr Aesthet Surg, 2016, 69(2): 149-162.
doi: 10.1016/j.bjps.2015.11.013 pmid: 26740288 |
[1] | XU Rui, WANG Zehao, WU Jiong. Advances in the role of tumor-associated neutrophils in the development of breast cancer [J]. China Oncology, 2024, 34(9): 881-889. |
[2] | CAO Xiaoshan, YANG Beibei, CONG Binbin, LIU Hong. The progress of treatment for brain metastases of triple-negative breast cancer [J]. China Oncology, 2024, 34(8): 777-784. |
[3] | ZHANG Jian. Clinical consideration of two key questions in assessing menopausal status of female breast cancer patients [J]. China Oncology, 2024, 34(7): 619-627. |
[4] | JIANG Dan, SONG Guoqing, WANG Xiaodan. Study on the mechanism of mitochondrial dysfunction and CPT1A/ERK signal transduction pathway regulating malignant behavior in breast cancer [J]. China Oncology, 2024, 34(7): 650-658. |
[5] | DONG Jianqiao, LI Kunyan, LI Jing, WANG Bin, WANG Yanhong, JIA Hongyan. A study on mechanism of SIRT3 inducing endocrine drug resistance in breast cancer via deacetylating YME1L1 [J]. China Oncology, 2024, 34(6): 537-547. |
[6] | HAO Xian, HUANG Jianjun, YANG Wenxiu, LIU Jinting, ZHANG Junhong, LUO Yubei, LI Qing, WANG Dahong, GAO Yuwei, TAN Fuyun, BO Li, ZHENG Yu, WANG Rong, FENG Jianglong, LI Jing, ZHAO Chunhua, DOU Xiaowei. Establishment of primary breast cancer cell line as new model for drug screening and basic research [J]. China Oncology, 2024, 34(6): 561-570. |
[7] | Committee of Breast Cancer Society, China Anti-Cancer Association. Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition) [J]. China Oncology, 2024, 34(3): 316-333. |
[8] | ZHANG Qi, XIU Bingqiu, WU Jiong. Progress of important clinical research of breast cancer in China in 2023 [J]. China Oncology, 2024, 34(2): 135-142. |
[9] | ZHANG Siyuan, JIANG Zefei. Important research progress in clinical practice for advanced breast cancer in 2023 [J]. China Oncology, 2024, 34(2): 143-150. |
[10] | WANG Zhaobu, LI Xing, YU Xinmiao, JIN Feng. Important research progress in clinical practice for early breast cancer in 2023 [J]. China Oncology, 2024, 34(2): 151-160. |
[11] | LUO Yang, SUN Tao, SHAO Zhimin, CUI Jiuwei, PAN Yueyin, ZHANG Qingyuan, CHENG Ying, LI huiping, YANG Yan, YE Changsheng, YU Guohua, WANG Jingfen, LIU Yunjiang, LIU Xinlan, ZHOU Yuhong, BAI Yuju, GU Yuanting, WANG Xiaojia, XU Binghe, SONG Lihua. Efficacy, metabolic characteristics, safety and immunogenicity of AK-HER2 compared with reference trastuzumab in patients with metastatic HER2-positive breast cancer: a multicenter, randomized, double-blind phase Ⅲ equivalence trial [J]. China Oncology, 2024, 34(2): 161-175. |
[12] | CHEN Yuanxiang, YU Tao, YANG Shiyu, ZENG Tao, WEI Lan, ZHANG Yan. KDM4A promotes the migration and invasion of breast cancer cell line MDA-MB-231 by downregulating BMP9 [J]. China Oncology, 2024, 34(2): 176-184. |
[13] | HU Xiaoyu, CAI Yuwen, YE Fugui, SHAO Zhimin, HU Weigang, YU Keda. Impact of BRCA1/2 germline mutation on the incidence of second primary cancer following postoperative radiotherapy in patients with triple-negative breast cancer [J]. China Oncology, 2024, 34(2): 185-190. |
[14] | ZHANG Siwei, MA Ding, JIANG Yizhou, SHAO Zhimin. “Subtype-precise” therapy leads diagnostic and therapeutic innovations: a new pattern for precision treatment of breast cancer [J]. China Oncology, 2024, 34(11): 1045-1052. |
[15] | OUYANG Fei, WANG Yang, CHEN Yu, PEI Guoqing, WANG Ling, ZHANG Yang, SHI Lei. Construction of the prediction model of breast cancer bone metastasis based on machine learning [J]. China Oncology, 2024, 34(10): 903-914. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
沪ICP备12009617
Powered by Beijing Magtech Co. Ltd